AKRON GENERAL MEDICAL CENTER — History
CCN 360027 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$774M
Latest Revenue (FY2022)
+10.0%
Revenue CAGR (3yr)
13.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $640M | $767M | $774M | +0.9% | +10.0% |
| Operating Expenses | $593M | $641M | $673M | +5.0% | +6.5% |
| Operating Margin | 7.3% | 16.4% | 13.1% | -20.4% | +33.4% |
| Net Income | $47M | $126M | $101M | -19.7% | +46.7% |
| Licensed Beds | 401 | 401 | 401 | +0.0% | +0.0% |
| Total Patient Days | 99,355 | 112,333 | 110,786 | -1.4% | +5.6% |
| Medicare Day % | 25% | 22% | 20% | -7.3% | -10.9% |
| Medicaid Day % | 3% | 3% | 4% | +43.4% | +14.1% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +20.9% ($640M → $774M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.0%
This Hospital
+7.6%
State Avg
Latest Margin
13.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $841M | 15.9% |
| FY2024 (proj) | $908M | 18.8% |
| FY2025 (proj) | $975M | 21.7% |